Silvercrest Asset Management Group LLC Bicycle Therapeutics PLC Transaction History
Silvercrest Asset Management Group LLC
- $14.7 Billion
- Q3 2025
A detailed history of Silvercrest Asset Management Group LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 476,976 shares of BCYC stock, worth $3.09 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
476,976
Previous 265,693
79.52%
Holding current value
$3.09 Million
Previous $1.85 Million
99.95%
% of portfolio
0.03%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding BCYC
# of Institutions
105Shares Held
38MCall Options Held
37.6KPut Options Held
3.7K-
Baker Bros. Advisors LP New York, NY10.9MShares$70.5 Million0.69% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$22.4 Million5.34% of portfolio
-
Armistice Capital, LLC New York, NY2.98MShares$19.3 Million0.35% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.95MShares$19.1 Million0.1% of portfolio
-
Siren, L.L.C. New York, NY2.01MShares$13 Million0.61% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $192M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...